domain CSL dont want to know them, i have spoken to senior management at gradipore and CSL arent open to discussions, they have blinkers on and are focused on their own existing tech. The ones to watch are Bayer and Aventis when it all settles down in the blood industry.
they also have an agreement with canadian co Cangene, check announcements a while back for news.
